Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.2100
-0.0700 (-25.00%)
At close: Jun 29, 2026, 4:00 PM EDT
0.2089
-0.0011 (-0.52%)
After-hours: Jun 29, 2026, 7:59 PM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $9.12 million as of June 29, 2026. Its market cap has decreased by -75.40% in one year.
Market Cap
9.12M
Enterprise Value
11.52M
1-Year Change
-75.40%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $9.12M, a decrease of -93.11%. That is a compound annual growth rate of -81.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 9.12M | -74.03% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.78M |
| BioRestorative Therapies | 9.48M |
| Jasper Therapeutics | 9.13M |
| Quoin Pharmaceuticals | 8.84M |
| Cadrenal Therapeutics | 8.81M |
| Ernexa Therapeutics | 8.46M |
| PharmaCyte Biotech | 8.16M |
| Aspire Biopharma Holdings | 8.07M |